BIO

Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products serving the scientific research, healthcare, and biopharmaceutical markets. The company develops, manufactures, and markets instruments, software, consumables, reagents, and content for a broad range of applications. Bio-Rad operates through two primary segments: Life Science (products for protein detection, genomics, cell biology research) and Clinical Diagnostics (quality controls, blood typing, diabetes monitoring, and autoimmune testing products). Founded in 1952 and headquartered in Hercules, California, Bio-Rad serves researchers, hospitals, clinical laboratories, and biopharmaceutical companies worldwide. The company is known for quality products, technical support, and comprehensive solutions for complex analytical techniques. Bio-Rad benefits from recurring revenue models, strong customer relationships, and essential applications in research and diagnostics. The company faces competition from larger life science companies and specialized diagnostic firms. Bio-Rad maintains a dual-class share structure with Class A common stock (BIO) and Class B common stock (BIO.B). The company continues to invest in product innovation, digital solutions, and strategic growth initiatives.